Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · IEX Real-Time Price · USD
8.03
0.00 (0.00%)
At close: Jul 19, 2024, 12:00 AM
8.09
+0.06 (0.75%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Orchestra BioMed Holdings Employees
Orchestra BioMed Holdings had 56 employees as of December 31, 2023.
Employees
56
Change
n/a
Growth
n/a
Revenue / Employee
$39,571
Profits / Employee
-$922,196
Market Cap
287.38M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AngioDynamics | 815 |
| MeiraGTx Holdings | 425 |
| Poseida Therapeutics | 330 |
| LifeMD | 211 |
| Omeros | 198 |
| Akebia Therapeutics | 167 |
| Alimera Sciences | 159 |
OBIO News
- 2 months ago - Orchestra BioMed to Participate in Jefferies Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 2 months ago - Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents - GlobeNewsWire
- 4 months ago - Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update - GlobeNewsWire
- 4 months ago - Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors - GlobeNewsWire
- 4 months ago - Orchestra BioMed to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients - GlobeNewsWire
- 7 months ago - Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients - GlobeNewsWire